Trimetazidine inhibits liver fibrosis and hepatic stellate cell proliferation and blocks transforming growth factor-β (TGFβ)/Smad signaling in vitro and in vivo

References

• Aydin MM, Akcali KC. Liver fibrosis. Turk J Gastroenterol. 2018 Jan;29(1):14–21.
   PubMed Web of Science ®Google Scholar
• Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019 Feb;65:37–55.
   PubMed Web of Science ®Google Scholar
• Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005 Feb;115(2):209–218.
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021 Mar;18(3):151–166.
   PubMed Web of Science ®Google Scholar
• Sun M, Kisseleva T. Reversibility of liver fibrosis. Clin Res Hepatol Gastroenterol. 2015 Sep;39(Suppl 1):S60–3.
   PubMedGoogle Scholar
• Seki E, Brenner DA. Recent advancement of molecular mechanisms of liver fibrosis. J Hepatobiliary Pancreat Sci. 2015 Jul;22(7):512–518.
   PubMed Web of Science ®Google Scholar
• Wu L, Luan Y, Li Y, et al. Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial. BMC Cardiovasc Disord. 2020 Jun 5;20(1):273.
   PubMed Web of Science ®Google Scholar
• Zhu K, Zheng YS, Fang Y. Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention: a protocol for systematic review and meta-analysis. Medicine (Baltimore). 2020 Oct 30;99(44):e22918.
   PubMed Web of Science ®Google Scholar
• Yaman M, Arslan U, Gumrukcuoglu HA, et al. Effects of trimetazidine on T wave alternans in stable coronary artery disease. Korean Circ J. 2016 May;46(3):343–349.
   PubMed Web of Science ®Google Scholar
• Blardi P, de Lalla A, Volpi L, et al. Increase of adenosine plasma levels after oral trimetazidine: a pharmacological preconditioning? Pharmacol Res. 2002 Jan;45(1):69–72.
   PubMed Web of Science ®Google Scholar
• Yang Q, Yang K, Li AY. Trimetazidine protects against hypoxia-reperfusion-induced cardiomyocyte apoptosis by increasing microRNA-21 expression. Int J Clin Exp Pathol. 2015;8(4):3735–3741.
   PubMed Web of Science ®Google Scholar
• Zhang H, Niu H, Yuan X, et al. Trimetazidine combined with berberine on endothelial function of patients with coronary heart disease combined with primary hypertension. Exp Ther Med. 2018 Aug;16(2):1318–1322.
   PubMed Web of Science ®Google Scholar
• Abdel-Salam OM, Mohammed NA, Sleem AA. The effects of trimetazidine on lipopolysaccharide-induced oxidative stress in mice. EXCLI J. 2011;10:162–172.
   PubMed Web of Science ®Google Scholar
• Iskesen I, Saribulbul O, Cerrahoglu M, et al. Trimetazidine reduces oxidative stress in cardiac surgery. Circ J. 2006 Sep;70(9):1169–1173.
   PubMed Web of Science ®Google Scholar
• Mahfoudh Boussaid A, Selmi R, Bejaoui M, et al. Effectiveness of a single versus repeated administration of trimetazidine in the protection against warm ischemia/reperfusion injury of rat liver. Turk J Med Sci. 2016 Jun 23;46(4):1258–1264.
   PubMed Web of Science ®Google Scholar
• Elimadi A, Sapena R, Settaf A, et al. Attenuation of liver normothermic ischemia–reperfusion injury by preservation of mitochondrial functions with S-15176, a potent trimetazidine derivative. Biochem Pharmacol. 2001 Aug 15;62(4):509–516.
   PubMed Web of Science ®Google Scholar
• Ateyya H, Yosef H, Nader MA. Ameliorative effect of trimetazidine on cisplatin-induced hepatotoxicity in rats. Can J Physiol Pharmacol. 2016 Feb;94(2):225–230.
   PubMed Web of Science ®Google Scholar
• Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017 Nov 1;121:27–42.
   PubMed Web of Science ®Google Scholar
• Li J, Wang Y, Ma M, et al. Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-beta signaling. EBioMedicine. 2019 Feb;40:43–55.
   PubMed Web of Science ®Google Scholar
• Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):397–411.
   PubMed Web of Science ®Google Scholar
• Kasuya A, Tokura Y. Attempts to accelerate wound healing. J Dermatol Sci. 2014 Dec;76(3):169–172.
   PubMed Web of Science ®Google Scholar
• Wu S, Chang G, Gao L, et al. Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy. J Mol Med (Berl). 2018 Aug;96(8):791–806.
   PubMed Web of Science ®Google Scholar
• Zhang L, Ding WY, Wang ZH, et al. Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy. J Transl Med. 2016 Apr 27;14(1):109.
   PubMed Web of Science ®Google Scholar
• Hazelhoff MH, Bulacio RP, Torres AM. Trimetazidine protects from mercury-induced kidney injury. Pharmacology. 2021;106(5–6):332–340.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li C, Li X, et al. Trimetazidine improves hepatic lipogenesis and steatosis in nonalcoholic fatty liver disease via AMPKChREBP pathway. Mol Med Rep. 2020 Sep;22(3):2174–2182.
   PubMedGoogle Scholar
• Wu BM, Liu JD, Li YH, et al. Margatoxin mitigates CCl4induced hepatic fibrosis in mice via macrophage polarization, cytokine secretion and STAT signaling. Int J Mol Med. 2020 Jan;45(1):103–114.
   PubMed Web of Science ®Google Scholar
• Wu H, Chen G, Wang J, et al. TIM-4 interference in Kupffer cells against CCL4-induced liver fibrosis by mediating Akt1/Mitophagy signalling pathway. Cell Prolif. 2020 Jan;53(1):e12731.
   PubMed Web of Science ®Google Scholar
• Xiang D, Zou J, Zhu X, et al. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-beta/Smad and YAP signaling. Phytomedicine. 2020 Nov;78:153294.
   PubMed Web of Science ®Google Scholar
• Hu HH, Chen DQ, Wang YN, et al. New insights into TGF-beta/Smad signaling in tissue fibrosis. Chem Biol Interact. 2018 Aug 25;292:76–83.
   PubMed Web of Science ®Google Scholar